FindTrial
Sign In

A prospective study to develop a predictive model for identifying the clinical phase of drug therapy for chronic subdural hematoma based on smartphone activity data

A prospective study to develop a predictive model for identifying the clinical phase of drug therapy for chronic subdural hematoma based on smartphone activity data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058268
Enrollment
Unknown
Registered
2022-04-04
Start date
2022-03-31
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Subdural Hematoma

Interventions

case series:None

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Chronic supratentorial subdural hematoma confirmed by imaging examination; 2. Markwalder-glasgow Coma Scale score 0-2; 3. Use an iOS or Android smartphone; 4. Conscious chronic subdural hematoma affects daily activities; 5. Aged >=18 years; 6. At least 12 weeks of outpatient follow-up.

Exclusion criteria

Exclusion criteria: 1. Cerebral hernias are high risk and/or require immediate surgical intervention; 2. Liver dysfunction or uncontrolled hepatitis; 3. Cancer; 4. Inability to walk and/or live independently.

Design outcomes

Primary

MeasureTime frame
steps/day;—

Countries

China

Contacts

Public ContactJiang Rongcai
jiang116216@163.com+86 13672116556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026